Shanghai Jiangeng Pharmaceutical Technology Co., Ltd. and the sponsor Guojin Securities Co., Ltd. withdrew their listing application, and the Shanghai Stock Exchange decided to terminate the review of their initial public offering of shares and listing on the Science and Technology Innovation Board.
上交所终止健耕医药科创板首发上市审核
The Shanghai Stock Exchange terminated the initial listing review of Jiangeng Pharmaceutical's Science and Technology Innovation Board
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.